Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Glod

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Pediatric Blood & Cancer|June 22, 2023
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumorLiny John, Hannah Smith, Maran Ilanchezhian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial UpdateAlice P Chen, Christina L Rosenberger, Nancy Moore, et al.
The New England Journal of Medicine|September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part SarcomaAlice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Cancer Cell|December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapySabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
The Lancet. Diabetes & Endocrinology|January 21, 2019
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective studyFrederic Castinetti, Steven G Waguespack, Andreas Machens, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Pediatric Blood & Cancer|June 22, 2023
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumorLiny John, Hannah Smith, Maran Ilanchezhian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial UpdateAlice P Chen, Christina L Rosenberger, Nancy Moore, et al.
The New England Journal of Medicine|September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part SarcomaAlice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Cancer Cell|December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapySabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
The Lancet. Diabetes & Endocrinology|January 21, 2019
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective studyFrederic Castinetti, Steven G Waguespack, Andreas Machens, et al.
Pageof 6